Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Post by longondmxon Apr 02, 2015 9:45am

142 Views

Post# 23590914

Some insider activity the last few days...nothing negative.

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Price
Apr 1/15	Mar 30/15	Blecher, Peter Martin	Control or Direction	Common Shares	47 - Acquisition by gift	100,000
Apr 1/15	Mar 30/15	Blecher, Peter Martin	Direct Ownership	Common Shares	47 - Disposition by gift	-100,000
Apr 1/15	Mar 27/15	Embro-Pantalony, Vaughn	Control or Direction	Common Shares	54 - Exercise of warrants	185,185	$0.400
Apr 1/15	Mar 27/15	Embro-Pantalony, Vaughn	Control or Direction	Warrants	54 - Exercise of warrants	-185,185